Alimera Sciences Balance Sheet Health
Financial Health criteria checks 2/6
Alimera Sciences has a total shareholder equity of $40.7M and total debt of $69.4M, which brings its debt-to-equity ratio to 170.8%. Its total assets and total liabilities are $152.5M and $111.8M respectively.
Key information
170.8%
Debt to equity ratio
US$69.44m
Debt
Interest coverage ratio | n/a |
Cash | US$14.31m |
Equity | US$40.65m |
Total liabilities | US$111.83m |
Total assets | US$152.49m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ASZ1's short term assets ($54.5M) exceed its short term liabilities ($20.8M).
Long Term Liabilities: ASZ1's short term assets ($54.5M) do not cover its long term liabilities ($91.0M).
Debt to Equity History and Analysis
Debt Level: ASZ1's net debt to equity ratio (135.6%) is considered high.
Reducing Debt: ASZ1's debt to equity ratio has reduced from 5894.7% to 170.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ASZ1 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ASZ1 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.